WhiteSwell Adds Experienced Executives to its Senior Management Team

With VP Clinical and VP Technical Operations, Company is Well Positioned for Next Phase of Growth

WhiteSwell Announces $30 Million Financing for New Therapeutic Approach to Acute Decompensated Heart Failure

Funds Will Support Product Development and Clinical Studies of Novel Catheter-Based Technology

WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart
Failure with Newly Issued U.S. Patent

Adds to Portfolio of 40 Patents for Catheter-Based Technology That Leverages Power of Body’s
Natural Fluid Removal Process

Catheter Stimulates Lymphatic Drainage for Heart Failure Treatment: Interview with Eamon Brady, CEO of WhiteSwell
Conn Hastings

Direct Interstitial Decongestion in an Animal Model of Acute-on-Chronic Ischemic Heart Failure
William T. Abraham, Michael Jonas, Ranjeet M. Dongaonkar, Beth Geist, Yukie Ueyama, Kevin Render, Brad Youngblood, William Muir, Robert Hamlin, and Carlos L. del Rio

Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review
Maxim Itkin, Stanley G. Rockson, and Daniel Burkhoff

Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week
Marat Fudim, Husam M. Salah, Janarthanan Sathananthan, Mathieu Bernier, Waleska Pabon-Ramos, Robert S. Schwartz, Josep Rodés-Cabau, François Côté, Abubaker Khalifa, Sean A. Virani, Manesh R. Patel

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
Giacomo Rossitto, Sheon Mary, Christine McAllister, Karla Bianca Neves, Laura Haddow, John Paul Rocchiccioli, Ninian Nicholas Lang, Clare Louise Murphy, Rhian Merry Touyz, Mark Colquhoun Petrie, Christian Delles